Back to TVTX

Kynam Capital Management, LP → TVTX

Kynam Capital Management, LP TVTX Position History

Travere Therapeutics, Inc. • Healthcare

Quarters held
6
Latest value
$117.8M
Q3 2026
Peak value
$117.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$19.8M
Q1 2026$46.6M
Q1 2026$23.8M
Q1 2026$1.6M
Q2 2026$113.6M
Q3 2026$117.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$117.8M2.00M——
Q2 2026$113.6M2.00M——
Q1 2026$1.6M54.9K——
Q1 2026$23.8M800.0K——
Q1 2026$46.6M1.57M——
Q4 2025$19.8M517.9K——

Other funds holding TVTX

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M